Article PDF
Avoid common mistakes on your manuscript.
References
Fukazawa T, Kikuchi S, Niino M, Yabe I, Hamada T, Tashiro K (2003) Multiphasic demyelinating disorder with acute transverse myelitis in Japanese. J Neurol 250:624–626
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477
Lennon VA, Wingerchuk DM, Kryzer T, Pittick SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112
Mandler RN, Ahmid W, Dencoff JE (1998) Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219–1220
Mandler RN, Davis LE, Jeffery DR, Kornfels M (1993) Devic's neuromyelitis optica: A clinicopathological study of 8 patients. Ann Neurol 34:162–168
Mei JF, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J (2006) Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis. J Neurol Sci 246:71–77
Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama I (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain 125:2460–2468
Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y (2005) An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 11:735–738
Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMOIgG. J Neurol Neurosurg Psychiatry 77:1073–1075
O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387
Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390–396
Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazana I, Nakamura M, Watanabe S, Ishii N, Itoyama Y (2006) Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210:307–313
Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130:1235–1243
Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107–1114
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimizu, Y., Yokoyama, K., Misu, T. et al. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255, 305–307 (2008). https://doi.org/10.1007/s00415-007-0730-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-007-0730-5